Inflammatory signaling pathway containing TRAF6 contributes to neointimal formation via diverse mechanisms

Takuya Miyahara1, Hiroyuki Koyama, Tetsuro Miyata

  • 1Department of Vascular Regeneration, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-8655, Japan.

Cardiovascular Research
|September 15, 2004
PubMed
Abstract

Insights

Tumor necrosis factor receptor-associated factor 6 (TRAF6) significantly contributes to neointimal formation after vascular injury. Inhibiting TRAF6 signaling reduces cell proliferation, migration, and inflammation, offering potential therapeutic targets.

Area of Science:

  • Vascular biology
  • Inflammation research
  • Molecular signaling

Background:

  • Neointimal formation is a key process in vascular restenosis after injury.
  • Inflammatory signaling pathways, including those involving TRAF6, are implicated in this process.

Purpose of the Study:

  • To investigate the role of tumor necrosis factor receptor-associated factor 6 (TRAF6) in neointimal hyperplasia.
  • To determine if inhibiting TRAF6 signaling can attenuate neointimal formation in a rabbit carotid artery balloon injury model.

Main Methods:

  • A dominant-negative (DN) form of TRAF6 was delivered to rabbit carotid arteries via in vivo electroporation following balloon injury.
  • The effects on inflammatory signaling (NF-kappaB, ERK1/2), cell proliferation, apoptosis, macrophage infiltration, and neointimal lesion size were assessed.

Main Results:

  • Successful delivery of TRAF6 DN plasmid and suppression of NF-kappaB activity were confirmed.
  • TRAF6 inhibition significantly reduced neointimal lesion formation, cell proliferation, macrophage accumulation, and migration.
  • Apoptosis was enhanced, and ERK1/2 activity was down-regulated post-injury.
  • TRAF6 inhibition also blocked intimal cell replication when applied even 7 days after injury.

Conclusions:

  • TRAF6 is a critical mediator of neointimal formation, influencing cell replication, migration, and inflammatory cell infiltration.
  • Targeting TRAF6 signaling presents a promising therapeutic strategy for preventing or treating vascular restenosis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...